J. Goldman & CO LP Esperion Therapeutics, Inc. Transaction History

J. Goldman & CO LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $1.32 Million - $2.2 Million	-259,146 Reduced 46.86%	293,864 $1.83 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $3.01 Million - $4.5 Million	553,010 New	553,010 $3.71 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $441,117 - $652,807	-22,738 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $481,600 - $707,255	-19,172 Reduced 45.75%	22,738 $638,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $694,709 - $1.03 Million	28,707 Added 217.43%	41,910 $1.09 Million
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $1.63 Million - $2.76 Million	-52,347 Reduced 79.86%	13,203 $491,000
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $1.97 Million - $3.36 Million	65,550 New	65,550 $3.36 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $446,201 - $1.2 Million	-16,261 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $575,639 - $972,733	16,261 New	16,261 $970,000
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $279,348 - $446,398	-7,552 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $3.47 Million - $4.38 Million	-85,139 Reduced 91.85%	7,552 $335,000
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $1.5 Million - $3.17 Million	41,444 Added 80.87%	92,691 $3.63 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $2.42 Million - $2.96 Million	36,670 Added 251.56%	51,247 $3.71 Million
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $671,307 - $1.04 Million	-15,443 Reduced 51.44%	14,577 $960,000
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $1.31 Million - $1.58 Million	30,020	30,020 $1.51 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.